These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32914559)

  • 1. Vascular amyloid accumulation alters the gabaergic synapse and induces hyperactivity in a model of cerebral amyloid angiopathy.
    Cisternas P; Taylor X; Perkins A; Maldonado O; Allman E; Cordova R; Marambio Y; Munoz B; Pennington T; Xiang S; Zhang J; Vidal R; Atwood B; Lasagna-Reeves CA
    Aging Cell; 2020 Oct; 19(10):e13233. PubMed ID: 32914559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy.
    Taylor X; Cisternas P; You Y; You Y; Xiang S; Marambio Y; Zhang J; Vidal R; Lasagna-Reeves CA
    J Neuroinflammation; 2020 Jul; 17(1):223. PubMed ID: 32711525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical traits of cerebral amyloid angiopathy in familial British-, Danish-, and non-Alzheimer's dementias.
    Michno W; Koutarapu S; Camacho R; Toomey C; Stringer K; Minta K; Ge J; Jha D; Fernandez-Rodriguez J; Brinkmalm G; Zetterberg H; Blennow K; Ryan NS; Lashley T; Hanrieder J
    J Neurochem; 2022 Nov; 163(3):233-246. PubMed ID: 36102248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy.
    You Y; Perkins A; Cisternas P; Muñoz B; Taylor X; You Y; Garringer HJ; Oblak AL; Atwood BK; Vidal R; Lasagna-Reeves CA
    Acta Neuropathol Commun; 2019 Feb; 7(1):26. PubMed ID: 30808415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy.
    Cisternas P; Taylor X; Lasagna-Reeves CA
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2.
    Vidal R; Barbeito AG; Miravalle L; Ghetti B
    Brain Pathol; 2009 Jan; 19(1):58-68. PubMed ID: 18410407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy.
    Robison LS; Popescu DL; Anderson ME; Francis N; Hatfield J; Sullivan JK; Beigelman SI; Xu F; Anderson BJ; Van Nostrand WE; Robinson JK
    J Neuroinflammation; 2019 Jul; 16(1):144. PubMed ID: 31296239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fruquintinib/HMPL-013 ameliorates cognitive impairments and pathology in a mouse model of cerebral amyloid angiopathy (CAA).
    Zhou G; Xiang T; Xu Y; He B; Wu L; Zhu G; Xie J; Yao L; Xiao Z
    Eur J Pharmacol; 2023 Jan; 939():175446. PubMed ID: 36470443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
    Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.
    Haglund M; Kalaria R; Slade JY; Englund E
    Acta Neuropathol; 2006 May; 111(5):430-5. PubMed ID: 16555084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral amyloid angiopathy.
    Yamada M; Naiki H
    Prog Mol Biol Transl Sci; 2012; 107():41-78. PubMed ID: 22482447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with five vascular risk factors causes cerebral amyloid angiopathy but no Alzheimer pathology in C57BL6 mice.
    Foidl BM; Humpel C
    Brain Behav Immun; 2019 May; 78():52-64. PubMed ID: 30664922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study.
    Marazuela P; Paez-Montserrat B; Bonaterra-Pastra A; Solé M; Hernández-Guillamon M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
    Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of ApoE inhibits ADan amyloidosis in a mouse model of familial Danish dementia.
    Fernandez A; Gomez MT; Vidal R
    J Biol Chem; 2023 Jan; 299(1):102751. PubMed ID: 36436561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral amyloid angiopathy and dementia.
    Tian J; Shi J; Mann DM
    Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.
    Herzig MC; Van Nostrand WE; Jucker M
    Brain Pathol; 2006 Jan; 16(1):40-54. PubMed ID: 16612981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human apolipoprotein E2 promotes parenchymal amyloid deposition and neuronal loss in vasculotropic mutant amyloid-β protein Tg-SwDI mice.
    Xu F; Vitek MP; Colton CA; Previti ML; Davis J; Van Nostrand WE
    J Alzheimers Dis; 2012; 31(2):359-69. PubMed ID: 22635103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
    Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
    Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.